| 1 |
Giraudo G, Greget M, Oussoultzoglou E, et al Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience[J]. Surgery, 2008,143(4):476-82.
|
| 2 |
Sirichindakul B, Nonthasoot B, Taesombat W. Role of portal vein embolization in hepatobiliary malignancy[J]. Hepatogastroenterology, 2007,54(80):2297-2300.
|
| 3 |
Palavecino M, Chun YS, Madoff DC, et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival[J]. Surgery, 2009,145(4):399-405.
|
| 4 |
Cotroneo AR, Innocenti P, Marano G, et al. Pre-hepatectomy portal vein embolization:single center experience[J]. Eur J Surg Oncol, 2009,35(1):71-78.
|
| 5 |
Yokoyama Y, Nagino M, Nishio H, et al. Recent advances in the treatment of hilar cholangiocarcinoma: portal vein embolization[J]. J Hepatobiliary Pancreat Surg, 2007,14(5):447-454.
|
| 6 |
Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant[J]. J Gastrointest Surg, 2008,12(2):297-303.
|
| 7 |
Mailey B, Truong C, Artinyan A, et al. Surgical resection of primary and metastatic hepatic malignancies following portal vein embolization[J]. J Surg Oncol, 2009,100(3):184-190.
|
| 8 |
Igami T, Yokoyama Y, Nishio H, et al. A left hepatectomy and caudate lobectomy combined resection of the ventral segment of the right anterior sector for hilar cholangiocarcinoma -the effi cacy of PVE in identifying the hepatic subsegment: report of a case[J]. Surg Today, 2009,39(7):628-632.
|
| 9 |
Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis[J]. Ann Surg, 2008,247(1):49-57.
|
| 10 |
Ribero D, Abdalla EK, Madoff DC, et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome[J]. Br J Surg, 2007,94(11):1386-1394.
|
| 11 |
Hwang S, Lee SG, Sung KB, et al. Hepatectomy for patients with transient hepatic failure after preoperative portal vein embolization[J]. Hepatogastroenterology, 2007,54(78):1817-1820.
|
| 12 |
Ingrid H, Ariane G, Peter S, et al. Adult stem cells in progression and therapy of hepatocellular carcinoma[J]. Int J Cancer, 2007,121(9):1875-1882.
|
| 13 |
Liu H, Zhu S. Present status and future perspectives of preoperative portal vein embolization[J]. Am J Surg, 2009,197(5):686-690.
|
| 14 |
van Gulik TM, van den Esschert JW, de Graaf W, et al. Controversies in the use of portal vein embolization[J]. Dig Surg, 2008,25(6):436-444.
|
| 15 |
Di Stefano DR, de Baere T, Denys A, et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients[J]. Radiology 2005,234(2):625-630.
|
| 16 |
Cho KA, Ju SY, Cho SJ, et a1. Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow[J]. Cell Biol Int, 2009,33(7):772-777.
|
| 17 |
Oyagi S, Hirose M, Kojima M, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats[J]. J Hepatol, 2006,44(4):742-748.
|
| 18 |
Okumoto K, Saito T, Haga H, et al. Characteristics of rat bone marrow cells differentiated into a liver cell lineage and dynamics of the transplanted cells in the injured liver[J]. J Gastroenterol, 2006,41(1):62-69.
|
| 19 |
Zhang YN, Lie PC, Wei X. Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells[J]. Cytotherapy, 2009,11(5):548-558.
|
| 20 |
Kazemnejad S, Allameh A, Seoleimani M, et al. Functional hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel 3-dimensional biocompatible nanofibrous scaffold[J]. Int J Artif Organs,2008,31(6):500-507.
|
| 21 |
Ying OL, Nichols J, Evans EP, et a1. Changing potency by spontaneous fusion[J]. Nature, 2002,416(6880):545-548.
|
| 22 |
Terada N, Hamazaki T, Oka M, et a1. Bone marow cells adopt the phenotype of other cells by cell fusio[J]. Nature, 2002,416(6880):542-545．
|
| 23 |
Fürst G, Schulte am Esch J, Poll LW, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration:Initial experience[J]. Radiology, 2007,243(1):171-179
|
| 24 |
Nikolic B, Elian M, Mertyna P, et al. The effect of hepatic radiofrequency ablation on stem cell trafficking in the rat model[J]. J Vasc Interv Radiol, 2009,20(5):640-647.
|
| 25 |
De Baere T, Denys A, Madoff DC. Preoperative portal vein embolization: indications and technical considerations[J]. Tech Vasc Interv Radiol, 2007,10(1):67-78.
|
| 26 |
Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care[J]. J Vasc Interv Radiol, 2005,16(6):779-790.
|
| 27 |
Liska V, Treska V, Mirka H, et al. Interleukin-6 augments activation of liver regneneration in porcine model in partial vein ligation[J]. Anticancer Research, 2009,29(6):2371-2378.
|
| 28 |
Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy[J]. Annals of Surgery, 2009,249(4):608-616.
|
| 29 |
Sugimoto T, Yamada T, Iwata H, et al. Two-stage portal vein ligation facilitates liver regeneration in rats[J]. Eur Surg Res,2009,42(3):181-188.
|
| 30 |
Lainas P, Boudechiche L, Osorio A, et al. Liver regeneration and recanalization time course following reversible portal vein embolization[J]. J Hepatol,2008,9(3):354-362.
|
| 31 |
Tsuda M, Kurihara N, Saito H, et al. Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma[J]. J Vasc Interv Radiol, 2006,17(6):989-994.
|
| 32 |
Nanashima A, Sumida Y, Abo T, et al. Clinical significance of portal vein embolization before right hepatectomy[J]. Hepatogastroenterology, 2009,56(91-92):773-777.
|
| 33 |
Bilbao JI, de Luis E, García de Jalón JA, et al. Comparative study of four different spherical embolic particles in an animal model: a morphologic and histologic evaluation[J]. J Vasc Interv Radiol, 2008,19(11):1625-1638.
|
| 34 |
Kakizawa H, Toyota N, Arihiro K, et al. Preoperative portal vein embolization with a mixture of gelatin sponge and iodized oil: efficacy and safety[J]. Acta Radiologica, 2006,47(10):1022-1028.
|
| 35 |
De Baere T, Denys A, Paradis V. Comparison of four embolic materials for portal vein embolization: experimental study in pigs[J]. Eur Radiol, 2009,19(6):1435-1442.
|
| 36 |
Bent CL, Low D, Matson MB, et al. Portal vein embolization using a nitinol plug (Amplatzer Vascular Plug) in combination with histoacryl glue and iodinized oil: adequate hypertrophy with a reduced risk of nontarget embolization[J]. Cardiovasc Intervent Radiol, 2009,32(3):471-477.
|
| 37 |
Ringe KI, Weidemann J, Rosenthal H, et al. Herbert rosenthal nshepatic peoperative portal vein embolization using the Amplatzer Vascular Plug: report of four cases[J]. Cardiovasc Intervent Radiol,2007(30):1245-1247.
|
| 38 |
Madoff DC, Gupta S, Pillsbury EP, et al. Transarterial versus Transhepatic portal vein embolization to induce selective hepatic hypertrophy: A comparative study in swine[J]. J Vasc Interv Radiol,2007,18(1 Pt 1):79-93.
|
| 39 |
Yoo H, Ko GY, Gwon DI etal.Preoperative portal vein embolization using an amplatzer vascular plug[J]. Eur Radiol.,2009 ,19(5):1054-1061.
|
| 40 |
Bae JH, Kim KC, Ryeom HK.Percutaneous preoperative portal vein embolization using a combination of gelatin sponge and histoacryl glue[J]. Acta Radio,2009,50(10):1119-1125.
|
| 41 |
Wicherts DA, de Haas RJ, Andreani P, et al. Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases[J]. Br J Surg, 2010,97(2):240-250.
|
| 42 |
Wisenberg G, Lekx K, Zabel P, et al. Cell tracking and therapy evaluation of bone marrow monocytes and stromal cells using SPECT and CMR in a canine model of myocardial infarction[J]. J Cardiovasc Magn Reson, 2009,11(1):11.
|
| 43 |
Schäfer R, Kehlbach R, Wiskirchen J, et al. Transferrin receptor upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide[J]. Radiology, 2007,244(2):514-523.
|
| 44 |
Yokoyama Y, Nagino M, Nimura Y. Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review[J]. World J Surg, 2007,31(2):367-374.
|
| 45 |
贾延颉，周燕.干细胞诱导分化为胰岛细胞的进展[J].中华内分泌代谢杂志，2004，20(1):87-89.
|
| 46 |
丁为民，田嘉禾.核医学显像活体示踪干细胞[J].同位素，2003，16(3-4):226-230.
|
| 47 |
段海峰，吴祖泽，陆颖，等.腺病毒介导的人HGF转染大鼠骨髓间充质干细胞及其作用研究[J].军事医学科学院院刊，2003，27(4):244-250.
|
| 48 |
徐迎新，王文杰，宋旭华，等．骨髓间充质干细胞定向肝细胞样分化的研究[J]．中华实验外科杂志，2004，21(2):152-153．
|
| 49 |
居胜红，滕皋军，毛曦，等.脐血间充质干细胞磁探针标记和磁共振成像研究[J].中华放射学杂志,2005,39(1):101-106.
|
| 50 |
孙军辉，滕皋军，居胜红，等.肾功能衰竭大鼠超顺磁性氧化铁标记骨髓间充质干细胞肾脏移植MR活体示踪的研究[J].中华放射学杂志,2006,40(2):144-148.
|
| 51 |
居胜红，滕皋军，陆海华，等.大鼠间充质干细胞超顺磁性氧化铁标记和经脾移植后的MR示踪研究[J].中华放射学杂志,2006,40(2):127-132.
|
| 52 |
腾皋军，居胜红.开展干细胞标记和MR活体示踪研究推进分子影像学发展[J].中华放射学杂志，2006，40(2):117-119.
|
| 53 |
余宏建，刘鹏程，陈在中，等.门静脉分支栓塞联合肝细胞生长因子应用对肝硬化肝脏再生的实验研究[J].医学影像学杂志，2007，17(4):397-401.
|
| 54 |
黄兢姚，杨维竹，江娜，等.经皮门静脉栓塞治疗肝癌的临床应用[J].介入放射学杂志，2006，15(11):664-666.
|
| 55 |
项灿宏，姚力，李启东，等.经皮经肝门静脉栓塞术在肝门部胆管癌手术中的应用[J].中国微创外科杂志，2007，7(1):50-53.
|
| 56 |
罗中华，孙立军，贺洪德，等.肝动脉化疗栓塞联合门静脉栓塞对非栓塞肝容积的影响[J].实用放射学杂志，2005，21(10):1070-1073.
|
| 57 |
嵇武，马宽生，董家鸿，等.术前选择性门静脉栓塞在肝癌二期切除中的应用[J].中华肝胆外科杂志，2003，9(6):348-351.
|
| 58 |
罗渝昆，梁萍，董宝玮，等.用A2氰基丙烯酸正丁酯胶穿刺栓塞大鼠门静脉的有效性与安全性研究[J].中国超声医学杂志，2002，18(3):168-172.
|
| 59 |
Tashiro S. Mechanism of liver regeneration after liver resection and portal vein embolization (ligation) is different[J]? J Hepatobiliary Pancreat Surg,2009,16(3):292-299.
|
| 60 |
Komori K, Nagino M, Nimura Y. Hepatocyte morphology and kinetics after portal vein embolization[J]. Br J Surg, 2006,93(6):745-751.
|